Merck KGaA (MRK: DE) has named Hong Chow head of China and international for its Healthcare business sector.
Starting on October 1, she will lead China, Japan as well as the regions of Europe, Latin America, Asia-Pacific and Middle East, Africa and Russia, and the franchise of cardiovascular metabolism and endocrinology (CM&E), and the global business innovation team.
Also serving as a member of the Healthcare executive committee, Ms Chow will be based in Shanghai, China.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze